Market revenue in 2022 | USD 374.6 million |
Market revenue in 2030 | USD 4,212.3 million |
Growth rate | 35.3% (CAGR from 2022 to 2030) |
Largest segment | Deep learning |
Fastest growing segment | Natural language processing |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.56% in 2022. Horizon Databook has segmented the North America artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
The Adventist nonprofit healthcare organization, Advent Health, announced in May 2021 that it would be working with the health intelligence company, Sema4. Using the software platform and tools from Sema4, the organizations will combine genomic and clinical data from Advent Health.
The collaboration represents an expansion of Advent Health's genomics and customized health initiative, including investments in precision medicine research and genetic testing, counseling, and sequencing. Similarly, in June 2019, the Icahn School of Medicine at Mount Sinai announced the launch of a USD 100 million research facility emphasizing AI and precision medicine in Manhattan in late 2021.
Precision imaging, the new Center for Genomic Health, and integrated omics & multiscale disease modeling will be the three principal research areas for the Hamilton and Amabel James Center for Artificial Intelligence and Human Health.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America artificial intelligence in precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into North America artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account